Studies of LV samples from patients with dilated cardiomyopathy or hypertrophic cardiomyopathy or with HFpEF associated with type 2 diabetes indicated that diminished phosphorylation of titin by PKGI contributes to these changes (3, 10, 11, 15, 32). Here, TTN is linked to hypertrophic cardiomyopathy.